Search Results - "Suvarna, Renuka"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-β agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis by Suvarna, Renuka, Shetty, Sahana, Pappachan, Joseph M.

    Published in Scientific reports (26-08-2024)
    “…Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important public health problem owing to its high prevalence and associated morbidity…”
    Get full text
    Journal Article
  2. 2

    The mechanistic role of neutrophil lymphocyte ratio perturbations in the leading non communicable lifestyle diseases [version 1; peer review: 2 approved] by Biswas, Monalisa, Suvarna, Renuka, Krishnan S, Vimal, Devasia, Tom, Shenoy Belle, Vijetha, Prabhu, Krishnananda

    Published in F1000 research (2022)
    “…Inflammation plays a critical role in the development and progression of chronic diseases like type 2 diabetes mellitus, coronary artery disease, and chronic…”
    Get full text
    Journal Article
  3. 3

    Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis by Suvarna, Renuka, Shenoy, Revathi P., Hadapad, Basavaraj S., Nayak, Anupama V.

    “…The mortality and morbidity rate of diabetes patients is increasing worldwide which requires an ideal treatment to prevent the disease worsening. Traditional…”
    Get full text
    Journal Article
  4. 4

    Acute and sub-chronic toxicity of Liberin, an anti-diabetic polyherbal formulation in rats by Suvarna, Renuka, Suryakanth, Varashree Bolar, Bakthavatchalam, Pugazhandhi, Kalthur, Guruprasad, Nayak M, Deepak, Prabhu, M Mukhyaprana, Hadapad, Basavaraj S, Shenoy, Revathi P

    “…The polyherbal formulation (PHF) liberin, is known to exert anti-hyperglycemic effects in type 2 diabetes mellitus. Hence, it is important to study the safety…”
    Get full text
    Journal Article
  5. 5

    Anthropometric indices and type 2 diabetes mellitus as a risk factor in predicting nonalcoholic fatty liver disease - A prospective study in Indian population by Suvarna, Renuka, Nasir, Mohammed, Stanley, Weena, Prabhu, M

    Published in Indian journal of community medicine (01-07-2022)
    “…Background: The different anthropometric indices have different predictive values of nonalcoholic fatty liver disease (NAFLD) in various populations. Since…”
    Get full text
    Journal Article
  6. 6

    Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials by Shetty, Sahana, Suvarna, Renuka

    Published in Diabetes, obesity & metabolism (01-03-2024)
    “…Aim Insulin icodec is a novel ultra‐long action basal insulin analogue designed for once‐weekly administration. With the merit of once‐a‐week administration,…”
    Get full text
    Journal Article
  7. 7

    Serum paraoxonase 1 activity status in patients with liver disorders by Kedage, Vivekananda, Muttigi, Manjunatha S, Shetty, Mahesh S, Suvarna, Renuka, Rao, Soumya S, Joshi, Chitralekha, Prakash, Mungli

    Published in Saudi journal of gastroenterology (01-04-2010)
    “…Paraoxonase 1 (PON1) is an esterase, exclusively synthesized by liver. The present study has two objectives: to determine the PON1 activity status in various…”
    Get full text
    Journal Article
  8. 8